Quarterly report · Q1
6523.TEDINET S100RO21
Period2023-04-01 → 2023-06-30
Filed2023-08-10
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥81.3bn | 2023-04-01 → 2023-06-30 | Cons. | Revenue IFRS |
| Revenue | ¥356.4bn | 2022-04-01 → 2023-03-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥81.5bn | 2022-04-01 → 2022-06-30 | Cons. | Revenue IFRS |
| Operating income | ¥1.7bn | 2023-04-01 → 2023-06-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥2.0bn | 2022-04-01 → 2022-06-30 | Cons. | Operating profit loss IFRS |
| Profit before tax | −¥3.6bn | 2023-04-01 → 2023-06-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥179m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | −¥6.3bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss before tax IFRS |
| Net income (owners) | −¥3.2bn | 2023-04-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | −¥3.2bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | −¥7.1bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | −¥3.1bn | 2023-04-01 → 2023-06-30 | Cons. | Profit loss IFRS |
| Net income | −¥7.0bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss IFRS |
| Total assets | ¥572.5bn | at 2023-06-30 | Cons. | Assets IFRS |
| Total assets | ¥561.6bn | at 2023-03-31 | Cons. | Assets IFRS |
| Total assets | ¥595.7bn | at 2022-06-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥428.9bn | at 2023-06-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥422.7bn | at 2023-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥143.7bn | at 2023-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥138.8bn | at 2023-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥137.7bn | at 2022-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥136.1bn | at 2022-03-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥144.0bn | at 2023-06-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥138.0bn | at 2023-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥136.9bn | at 2022-06-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥54.1bn | at 2023-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥60.9bn | at 2023-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥82.1bn | at 2022-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥95.2bn | at 2022-03-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥8.2bn | 2023-04-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥21.4bn | 2022-04-01 → 2023-03-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥1.9bn | 2022-04-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥3.5bn | 2023-04-01 → 2023-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥17.5bn | 2022-04-01 → 2023-03-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥5.2bn | 2022-04-01 → 2022-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | −¥14.4bn | 2023-04-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥40.8bn | 2022-04-01 → 2023-03-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥11.9bn | 2022-04-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥-25.5 | 2023-04-01 → 2023-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥-25.84 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥-57.26 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥-25.5 | 2023-04-01 → 2023-06-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥-25.84 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥-57.26 | 2022-04-01 → 2022-06-30 | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 25.2% | at 2023-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 24.6% | at 2023-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 23.0% | at 2022-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-06-30 | ¥568m |
| Reconciling Itemsreconciling | revenue external | 2023-04-01 → 2023-06-30 | ¥568m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-06-30 | −¥2.2bn |
| jpcrp040300-q1r_E36976-000Diabetes Managementreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥25.4bn |
| jpcrp040300-q1r_E36976-000Diabetes Managementreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥25.4bn |
| jpcrp040300-q1r_E36976-000Diabetes Managementreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥1.6bn |
| jpcrp040300-q1r_E36976-000Diagnostics And Life Sciencesreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥24.5bn |
| jpcrp040300-q1r_E36976-000Diagnostics And Life Sciencesreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥24.5bn |
| jpcrp040300-q1r_E36976-000Diagnostics And Life Sciencesreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E36976-000Healthcare Solutionsreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥30.8bn |
| jpcrp040300-q1r_E36976-000Healthcare Solutionsreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥30.8bn |
| jpcrp040300-q1r_E36976-000Healthcare Solutionsreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥1.2bn |
| —segment total | revenue | 2023-04-01 → 2023-06-30 | ¥80.8bn |
| —segment total | revenue external | 2023-04-01 → 2023-06-30 | ¥80.8bn |
| —segment total | segment profit | 2023-04-01 → 2023-06-30 | ¥3.9bn |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-06-30 | ¥552m |
| Reconciling Itemsreconciling | revenue external | 2022-04-01 → 2022-06-30 | ¥552m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | −¥6.7bn |
| jpcrp040300-q1r_E36976-000Diabetes Managementreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥26.5bn |
| jpcrp040300-q1r_E36976-000Diabetes Managementreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥26.5bn |
| jpcrp040300-q1r_E36976-000Diabetes Managementreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥5.5bn |
| jpcrp040300-q1r_E36976-000Diagnostics And Life Sciencesreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥23.4bn |
| jpcrp040300-q1r_E36976-000Diagnostics And Life Sciencesreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥23.4bn |
| jpcrp040300-q1r_E36976-000Diagnostics And Life Sciencesreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥1.2bn |
| jpcrp040300-q1r_E36976-000Healthcare Solutionsreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥31.1bn |
| jpcrp040300-q1r_E36976-000Healthcare Solutionsreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥31.1bn |
| jpcrp040300-q1r_E36976-000Healthcare Solutionsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥2.0bn |
| —segment total | revenue | 2022-04-01 → 2022-06-30 | ¥80.9bn |
| —segment total | revenue external | 2022-04-01 → 2022-06-30 | ¥80.9bn |
| —segment total | segment profit | 2022-04-01 → 2022-06-30 | ¥8.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 864
| Item | Context | Value | Unit |
|---|---|---|---|
| Total transactions with owners IFRS | Prior1YTDDuration_RetainedEarningsIFRSMember | -3034000000 | JPY |
| Total transactions with owners IFRS | Prior1YTDDuration_TreasurySharesIFRSMember | - | JPY |
| Total transactions with owners IFRS | Prior1YTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember | -1182000000 | JPY |
| Total transactions with owners IFRS | Prior1YTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember | - | JPY |
| Total transactions with owners IFRS | Prior1YTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember | - | JPY |
| Equity IFRS | Prior1QuarterInstant_ShareCapitalIFRSMember | 47431000000 | JPY |
| Equity IFRS | Prior1QuarterInstant_CapitalSurplusIFRSMember | 43509000000 | JPY |
| Equity IFRS | Prior1QuarterInstant_RetainedEarningsIFRSMember | 18211000000 | JPY |
| Equity IFRS | Prior1QuarterInstant_TreasurySharesIFRSMember | -568000000 | JPY |
| Equity IFRS | Prior1QuarterInstant_RemeasurementsOfDefinedBenefitPlansIFRSMember | - | JPY |
| Equity IFRS | Prior1QuarterInstant_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember | 467000000 | JPY |
| Equity IFRS | Prior1QuarterInstant_EffectivePortionOfCashFlowHedgesIFRSMember | -2000000 | JPY |
| Equity IFRS | Prior2YearInstant_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember | 15753000000 | JPY |
| Equity IFRS | Prior2YearInstant_ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember | 333000000 | JPY |
| Equity IFRS | Prior2YearInstant_jpcrp040300-q1r_E36976-000OtherComponentsOfEquityRelatedToDisposalGroupsClassifiedAsHeldForSaleIFRSMember | - | JPY |
| Equity IFRS | Prior2YearInstant_OtherComponentsOfEquityIFRSMember | 16406000000 | JPY |
| Equity IFRS | Prior2YearInstant_EquityAttributableToOwnersOfParentIFRSMember | 135374000000 | JPY |
| Equity IFRS | Prior2YearInstant_NonControllingInterestsIFRSMember | 690000000 | JPY |
| Equity IFRS | Prior2YearInstant | 136065000000 | JPY |
| Profit loss IFRS | Prior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember | - | JPY |
| Profit loss IFRS | Prior1YTDDuration_ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember | - | JPY |
| Profit loss IFRS | Prior1YTDDuration_jpcrp040300-q1r_E36976-000OtherComponentsOfEquityRelatedToDisposalGroupsClassifiedAsHeldForSaleIFRSMember | - | JPY |
| Profit loss IFRS | Prior1YTDDuration_OtherComponentsOfEquityIFRSMember | - | JPY |
| Profit loss IFRS | Prior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember | -7106000000 | JPY |
| Profit loss IFRS | Prior1YTDDuration_NonControllingInterestsIFRSMember | 67000000 | JPY |
| Profit loss IFRS | Prior1YTDDuration | -7038000000 | JPY |
| Other comprehensive income IFRS | Prior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember | 11419000000 | JPY |
| Other comprehensive income IFRS | Prior1YTDDuration_ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember | 307000000 | JPY |
| Other comprehensive income IFRS | Prior1YTDDuration_jpcrp040300-q1r_E36976-000OtherComponentsOfEquityRelatedToDisposalGroupsClassifiedAsHeldForSaleIFRSMember | - | JPY |
| Other comprehensive income IFRS | Prior1YTDDuration_OtherComponentsOfEquityIFRSMember | 13055000000 | JPY |
| Other comprehensive income IFRS | Prior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember | 13055000000 | JPY |
| Other comprehensive income IFRS | Prior1YTDDuration_NonControllingInterestsIFRSMember | 73000000 | JPY |
| Other comprehensive income IFRS | Prior1YTDDuration | 13128000000 | JPY |
| Comprehensive income IFRS | Prior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember | 11419000000 | JPY |
| Comprehensive income IFRS | Prior1YTDDuration_ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember | 307000000 | JPY |
| Comprehensive income IFRS | Prior1YTDDuration_jpcrp040300-q1r_E36976-000OtherComponentsOfEquityRelatedToDisposalGroupsClassifiedAsHeldForSaleIFRSMember | - | JPY |
| Comprehensive income IFRS | Prior1YTDDuration_OtherComponentsOfEquityIFRSMember | 13055000000 | JPY |
| Comprehensive income IFRS | Prior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember | 5948000000 | JPY |
| Comprehensive income IFRS | Prior1YTDDuration_NonControllingInterestsIFRSMember | 141000000 | JPY |
| Comprehensive income IFRS | Prior1YTDDuration | 6089000000 | JPY |
| Issuance of new shares ss IFRS | Prior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember | - | JPY |
| Issuance of new shares ss IFRS | Prior1YTDDuration_ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember | - | JPY |
| Issuance of new shares ss IFRS | Prior1YTDDuration_jpcrp040300-q1r_E36976-000OtherComponentsOfEquityRelatedToDisposalGroupsClassifiedAsHeldForSaleIFRSMember | - | JPY |
| Issuance of new shares ss IFRS | Prior1YTDDuration_OtherComponentsOfEquityIFRSMember | - | JPY |
| Issuance of new shares ss IFRS | Prior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember | 100000000 | JPY |
| Issuance of new shares ss IFRS | Prior1YTDDuration_NonControllingInterestsIFRSMember | - | JPY |
| Issuance of new shares ss IFRS | Prior1YTDDuration | 100000000 | JPY |
| Dividends to owners of parent ss IFRS | Prior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember | - | JPY |
| Dividends to owners of parent ss IFRS | Prior1YTDDuration_ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember | - | JPY |
| Dividends to owners of parent ss IFRS | Prior1YTDDuration_jpcrp040300-q1r_E36976-000OtherComponentsOfEquityRelatedToDisposalGroupsClassifiedAsHeldForSaleIFRSMember | - | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |